A preliminary study of dopamine D2/3 receptor availability and social status in healthy and cocaine dependent humans imaged with [11C](+)PHNO

Drug and Alcohol Dependence

Volumn 154, Issue , 2015, Pages 167-173

  Matuskey, David ^a,b   Gaiser, Edward C ^a,b   Gallezot, Jean Dominique ^a   Angarita, Gustavo A ^b   Pittman, Brian ^b   Nabulsi, Nabeel ^a   Ropchan, Jim ^a   MaCleod, Paige ^b   Cosgrove, Kelly P ^a,b   Ding, Yu Shin ^c   Potenza, Marc N ^a,b   Carson, Richard E ^a   Malison, Robert T ^b  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Dopamine; PET imaging; Social status; 11C (+)PHNO

Indexed keywords

CARBON 11; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; NAXAGOLIDE; DOPAMINE RECEPTOR STIMULATING AGENT; OXAZINE DERIVATIVE;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BODY MASS; CAUDATE NUCLEUS; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GLOBUS PALLIDUS; HUMAN; HYPOTHALAMUS; MALE; PRIORITY JOURNAL; PUTAMEN; SOCIAL STATUS; SUBSTANTIA NIGRA; THALAMUS; VENTRAL STRIATUM; VENTRAL TEGMENTUM; AMYGDALA; CASE CONTROL STUDY; FUNCTIONAL NEUROIMAGING; METABOLISM; POSITRON EMISSION TOMOGRAPHY; SOCIAL DOMINANCE; YOUNG ADULT;

PRIMATES;

ADULT; AMYGDALA; CASE-CONTROL STUDIES; COCAINE-RELATED DISORDERS; DOPAMINE AGONISTS; FEMALE; FUNCTIONAL NEUROIMAGING; HIERARCHY, SOCIAL; HUMANS; MALE; OXAZINES; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SUBSTANTIA NIGRA; VENTRAL TEGMENTAL AREA; YOUNG ADULT;

EID: 84938995506     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.06.039     Document Type: Article

References (51)

1. Abi-Dargham A., Rodenhiser J., Printz D., Zea-Ponce Y., Gil R., Kegeles L.S., Weiss R., Cooper T.B., Mann J.J., Van Heertum R.L., Gorman J.M., Laruelle M. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:8104-8109.
2. Adler N.E., Boyce T., Chesney M.A., Cohen S., Folkman S., Kahn R.L., Syme S.L. Socioeconomic status and health. The challenge of the gradient. Am. Psychol. 1994, 49:15-24.
3. American Psychiatric Association, Task Force on DSM-IV Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR 2000, American Psychiatric Association, Washington, DC.
4. Barratt W. The Barratt Simplified Measure of Social Status (BSMSS) measuring SES. 2006, Available from: http://wbarratt.indstate.edu/socialclass/Barratt_Simplifed_Measure_of_Social_Status.pdf.
5. 11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. J. Neurosci. 2012, 32:1353-1359.
6. Caravaggio F., Nakajima S., Borlido C., Remington G., Gerretsen P., Wilson A., Houle S., Menon M., Mamo D., Graff-Guerrero A. Estimating endogenous dopamine levels at D and D receptors in humans using the agonist radiotracer [C]-(+)-PHNO. Neuropsychopharmacology 2014, 39:2769-2776.
7. Caravaggio F., Raitsin S., Gerretsen P., Nakajima S., Wilson A., Graff-Guerrero A. Ventral striatum binding of a dopamine d receptor agonist but not antagonist predicts normal body mass index. Biol. Psychiatry 2013, 77:196-202.
8. Carson R.E., Barker W.C., Liow J.-S., Johnson C.A. Design of a motion compensation OSEM list-mode algorithm for resolution-recovery reconstruction of the HRRT. Conference Record, IEEE Nuclear Science Symposium and Medical Imaging Conference 2003, 3281-3285.
9. 11C](+)PHNO in healthy male and female volunteers. Biol. Psychiatry 2014, Suppl. 75:403S-426S. 406S.
10. Cozolino L.J. The Neuroscience of Human Relationships: Attachment and the Developing Social Brain 2014, W.W. Norton & Company, New York.
11. Czoty P.W., Gage H.D., Nader M.A. Differences in D2 dopamine receptor availability and reaction to novelty in socially housed male monkeys during abstinence from cocaine. Psychopharmacology 2010, 208:585-592.
12. Czoty P.W., Morgan D., Shannon E.E., Gage H.D., Nader M.A. Characterization of dopamine D1 and D2 receptor function in socially housed cynomolgus monkeys self-administering cocaine. Psychopharmacology 2004, 174:381-388.
13. Erritzoe D., Tziortzi A., Bargiela D., Colasanti A., Searle G.E., Gunn R.N., Beaver J.D., Waldman A., Nutt D.J., Bani M., Merlo-Pich E., Rabiner E.A., Lingford-Hughes A. In vivo imaging of cerebral dopamine D3 receptors in alcoholism. Neuropsychopharmacology 2014, 39:1703-1712.
14. Gallezot J.D., Beaver J.D., Gunn R.N., Nabulsi N., Weinzimmer D., Singhal T., Slifstein M., Fowles K., Ding Y.S., Huang Y., Laruelle M., Carson R.E., Rabiner E.A. Affinity and selectivity of [(1)(1)C]-(+)-PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo. Synapse 2012, 66:489-500.
15. Gallezot J.D., Kloczynski T., Weinzimmer D., Labaree D., Zheng M.Q., Lim K., Rabiner E.A., Ridler K., Pittman B., Huang Y., Carson R.E., Morris E.D., Cosgrove K.P. Imaging nicotine- and amphetamine-induced dopamine release in rhesus monkeys with [(11)C]PHNO vs [(11)C]raclopride PET. Neuropsychopharmacology 2014, 39:866-874.
16. 11C-(+)-PHNO binding to D2/D3 Dopamine receptors in humans on the high-resolution research tomograph PET scanner. J. Nucl. Med. 2014, 55:960-966.
17. George S.R., Watanabe M., Di Paolo T., Falardeau P., Labrie F., Seeman P. The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form. Endocrinology 1985, 117:690-697.
18. 11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography. J. Neurochem. 2006, 97:1089-1103.
19. 11C]-(+)-PHNO binding in the human brain. J. Cereb. Blood Flow Metab. 2007, 27:857-871.
20. 11C]raclopride in healthy humans. Hum. Brain Mapp. 2008, 29:400-410.
21. Grant K.A., Shively C.A., Nader M.A., Ehrenkaufer R.L., Line S.W., Morton T.E., Gage H.D., Mach R.H. Effect of social status on striatal dopamine D2 receptor binding characteristics in cynomolgus monkeys assessed with positron emission tomography. Synapse 1998, 29:80-83.
22. Hall F.S., Wilkinson L.S., Humby T., Inglis W., Kendall D.A., Marsden C.A., Robbins T.W. Isolation rearing in rats: pre- and postsynaptic changes in striatal dopaminergic systems. Pharmacol. Biochem. Behav. 1998, 59:859-872.
23. Hollingshead A.B. Four Factor Index of Social Status 1975, Department of Sociology, Yale University, New Haven, CT, (working paper published by the author).
24. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.C., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., Carson R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 2007, 27:1533-1539.
25. Ishibashi K., Ishii K., Oda K., Kawasaki K., Mizusawa H., Ishiwata K. Regional analysis of age-related decline in dopamine transporters and dopamine D2-like receptors in human striatum. Synapse 2009, 63:282-290.
26. Kessler R.M., Zald D.H., Ansari M.S., Li R., Cowan R.L. Changes in dopamine release and dopamine D2/3 receptor levels with the development of mild obesity. Synapse 2014, 68:317-320.
27. Kim J.H., Son Y.D., Kim H.K., Lee S.Y., Cho S.E., Kim Y.B., Cho Z.H. Effects of age on dopamine D2 receptor availability in striatal subdivisions: a high-resolution positron emission tomography study. Eur. Neuropsychopharmacol. 2011, 21:885-891.
28. Laruelle M., D'Souza C.D., Baldwin R.M., Abi-Dargham A., Kanes S.J., Fingado C.L., Seibyl J.P., Zoghbi S.S., Bowers M.B., Jatlow P., Charney D.S., Innis R.B. Imaging D2 receptor occupancy by endogenous dopamine in humans. Neuropsychopharmacology 1997, 17:162-174.
29. 11C]-+-PHNO PET study in humans. Neuropsychopharmacology 2014, 39:415-424.
30. Leff P. The two-state model of receptor activation. Trends Pharmacol. Sci. 1995, 16:89-97.
31. Martinez D., Greene K., Broft A., Kumar D., Liu F., Narendran R., Slifstein M., Van Heertum R., Kleber H.D. Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion. Am. J. Psychiatry 2009, 166:1170-1177.
32. Martinez D., Orlowska D., Narendran R., Slifstein M., Liu F., Kumar D., Broft A., Van Heertum R., Kleber H.D. Dopamine type 2/3 receptor availability in the striatum and social status in human volunteers. Biol. Psychiatry 2010, 67:275-278.
33. Matuskey D., Gallezot J.D., Pittman B., Williams W., Wanyiri J., Gaiser E., Lee D.E., Hannestad J., Lim K., Zheng M.Q., Lin S.F., Labaree D., Potenza M.N., Carson R.E., Malison R.T., Ding Y.S. Dopamine D(3) receptor alterations in cocaine-dependent humans imaged with [(1)(1)C](+)PHNO. Drug Alcohol Depend. 2014, 139:100-105.
34. Mawlawi O., Martinez D., Slifstein M., Broft A., Chatterjee R., Hwang D.R., Huang Y., Simpson N., Ngo K., Van Heertum R., Laruelle M. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J. Cereb. Blood Flow Metab. 2001, 21:1034-1057.
35. 11C]-(+)-PHNO. Schizophr. Res. 2011, 131:63-68.
36. Morgan D., Grant K.A., Gage H.D., Mach R.H., Kaplan J.R., Prioleau O., Nader S.H., Buchheimer N., Ehrenkaufer R.L., Nader M.A. Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat. Neurosci. 2002, 5:169-174.
37. Morgan D., Grant K.A., Prioleau O.A., Nader S.H., Kaplan J.R., Nader M.A. Predictors of social status in cynomolgus monkeys (Macaca fascicularis) after group formation. Am. J. Primatol. 2000, 52:115-131.
38. Nader M.A., Banks M.L. Environmental modulation of drug taking: nonhuman primate models of cocaine abuse and PET neuroimaging. Neuropharmacology 2014, 76:510-517.
39. 11C]NPA positron emission tomography study. Synapse 2011, 65:1344-1349.
40. 11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo. Synapse 2006, 60:485-495.
41. Payer D.E., Behzadi A., Kish S.J., Houle S., Wilson A.A., Rusjan P.M., Tong J., Selby P., George T.P., McCluskey T., Boileau I. Heightened D(3) dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [(11)C]-(+)-PHNO. Neuropsychopharmacology 2014, 39:311-318.
42. 11C]PHNO, and a selective D3 receptor antagonist. Biol. Psychiatry 2010, 68:392-399.
43. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl. 20):22-33. quiz 34-57.
44. Shotbolt P., Tziortzi A.C., Searle G.E., Colasanti A., van der Aart J., Abanades S., Plisson C., Miller S.R., Huiban M., Beaver J.D., Gunn R.N., Laruelle M., Rabiner E.A. Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans. J. Cereb. Blood Flow Metab. 2012, 32:127-136.
45. Tamashiro K.L., Nguyen M.M., Sakai R.R. Social stress: from rodents to primates. Front. Neuroendocrinol. 2005, 26:27-40.
46. 11C]-(+)-PHNO: dissection of D3 signal and anatomy. Neuroimage 2011, 54:264-277.
47. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15:273-289.
48. Volkow N.D., Logan J., Fowler J.S., Wang G.J., Gur R.C., Wong C., Felder C., Gatley S.J., Ding Y.S., Hitzemann R., Pappas N. Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Am. J. Psychiatry 2000, 157:75-80.
49. Wang G.J., Volkow N.D., Logan J., Pappas N.R., Wong C.T., Zhu W., Netusil N., Fowler J.S. Brain dopamine and obesity. Lancet 2001, 357:354-357.
50. 11C]-(+)-PHNO positron emission tomography study. Neuropsychopharmacology 2008, 33:279-289.
51. Wu Y., Carson R.E. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J. Cereb. Blood Flow Metab. 2002, 22:1440-1452.